SEP 15·SEC EDGARLow
Maheshwari Shubham sold $2.4M of VREX
Maheshwari Shubham (Chief Financial Officer) sold 130,000 shares of Varex Imaging Corp (VREX) at $18.46 ($2.40M total) on 2026-09-11.
StockNASDAQ · US · USDHealthcare · Medical Devices
$VREX
Varex Imaging Corp
AlphAI earnings readThird quarter fiscal year 2026 · AUG 10Varex announces financial results for third quarter fiscal year 2026Verdict: solidRead →
Reads like this one publish minutes after the filing lands on EDGAR. Get them as JSON over the API or inside your AI agent over MCP.
Price · $VREXvia TradingView
AI sentiment · 7d0 articles
No enriched coverage for $VREX in the last 7 days.
Insider · 30dAll trades →
- Buys
- — 0 txs
- Sells
- $2.6M 2 txs
Kunkel Jay K.1× · $150K
10b5-1 share of filings0%
Top stories · $VREXMore →
SEP 15·SEC EDGAR
Kunkel Jay K. sold $150K of VREX
Kunkel Jay K. sold 8,121 shares of Varex Imaging Corp (VREX) at $18.48 ($0.15M total) on 2026-09-14.
SEP 11·stocktitan.net
Varex Imaging (NASDAQ: VREX) filer plans $2.4M stock sale
Varex Imaging (VREX) shareholder Shubham Maheshwari plans to sell 130,000 shares, valued at approximately $2.4M, under Rule 144. The sale is tied to a stock option exercise and is expected to occur on September 11, 2026.
VREX sentiment & insider activity
Recent VREX coverage spans mergers & acquisitions, insider activity and financial news.
In the last 30 days, VREX insiders filed 2 SEC Form 4 transactions — no purchases and 2 sales ($2.6M). The most active reporter was Kunkel Jay K. with 1 filing.
What's driving VREX
Insider sale by the CFO may signal reduced confidence, potentially pressuring the stock short-term.
Minor dilution of insider ownership may slightly pressure the stock.
Minor dilution from insider stock sale; limited price impact.
Shareholders receive a premium; stock may trade up to deal price.
Shareholders receive a cash premium; stock likely to trade near the offer price.
AlphAI scores every news story that mentions VREX with an AI model for sentiment and relevance, and aggregates insider trades from Varex Imaging Corp's SEC EDGAR Form 4 filings. Figures refresh continuously.
News on $VREX
Score
Maheshwari Shubham sold $2.4M of VREX
Maheshwari Shubham (Chief Financial Officer) sold 130,000 shares of Varex Imaging Corp (VREX) at $18.46 ($2.40M total) on 2026-09-11.
1 min readKunkel Jay K. sold $150K of VREX
Kunkel Jay K. sold 8,121 shares of Varex Imaging Corp (VREX) at $18.48 ($0.15M total) on 2026-09-14.
1 min readVarex Imaging (NASDAQ: VREX) filer plans $2.4M stock sale
Varex Imaging (VREX) shareholder Shubham Maheshwari plans to sell 130,000 shares, valued at approximately $2.4M, under Rule 144. The sale is tied to a stock option exercise and is expected to occur on September 11, 2026.
1 min read
Teledyne to Acquire Varex Imaging in $1.1 Billion Deal – Metrology and Quality News
Teledyne Technologies (TDY) will acquire Varex Imaging (VREX) for $1.1 billion, including net debt and equity awards. The deal, approved by both boards, is expected to close in early 2027. Varex's X-ray technologies complement Teledyne's offerings, with minimal product overlap. The acquisition aims to accelerate Varex's product development and adoption.
2 min read
Los Angeles Business Journal
Teledyne Technologies (TDY) agreed to acquire Varex Imaging (VREX) for $1.1B, or $18.90 per share in cash. The deal is expected to close in 2027. Varex's X-ray imaging tech complements Teledyne's portfolio, according to Varex's CEO. Teledyne has previously acquired firms in the healthcare sector, including Dalsa Corp. and DD-Scientific.
2 min read
Strategic Consolidation in Medical Imaging: Analysis of Teledyne Technologies' Acquisition of Varex Imaging
Teledyne (NYSE: TDY) agreed to buy Varex Imaging (NASDAQ: VREX) in an all-cash merger for $18.90 per share, valuing the deal at about $1.1 billion including net debt and equity awards. Boards approved unanimously; closing expected early 2027. Varex reported Q3 FY2026 revenue of $210.5M and GAAP net income of $15.7M.
7 min readWeekly Buzz: LNTH, CBLL Win FDA Nod; AURA Cuts Jobs; TDY Buys VREX; CGEM, DFTX Meet Trial Goals
Biopharma roundup reported FDA/EC approvals and trial updates for Lantheus (LNTH) TAUKLARIFY, Ceribell (CBLL) AI EEG algorithms, Labcorp (LH) PGDx CDx, and EU/UK approvals for Galderma (GDERF) Restylane Shaype and Rhythm (RYTM) IMCIVREE. GRAIL (GRAL) faces an FDA panel on Sept. 23. Teledyne (TDY) to buy Varex (VREX) for about $1.1B; Aura (AURA) cut 20% staff.
7 min read
Why Is Teledyne Technologies (TDY) Paying a 52% Premium for Varex (VREX)?
Teledyne Technologies (NYSE:TDY) agreed to acquire Varex Imaging (NASDAQ:VREX) for $18.90 per share in cash, a 52% premium to Varex’s unaffected close. The deal values Varex at about $1.1 billion including equity awards and net debt. Varex jumped 48.5% to $18.42 on Aug. 10; TDY fell slightly. Teledyne cited synergies but did not quantify EPS accretion.
6 min read
Teledyne to Acquire Varex Imaging Corporation
Teledyne Technologies agreed to acquire Varex Imaging in a cash deal for $18.90 per Varex share, valuing the transaction at about $1.1 billion including equity awards and net debt as of April 3, 2026. Boards approved unanimously. Closing is expected in early 2027, pending regulatory and Varex stockholder approvals.
4 min read
Five Months After a $490 Million Refinancing, Utah’s Varex Imaging Agrees to be Acquired by Teledyne in a $1.1 Billion Deal
Varex Imaging (NASDAQ:VREX) agreed to be acquired by Teledyne Technologies (NYSE:TDY) for $18.90 per share in a cash deal valued at about $1.1 billion, including Varex equity awards and net debt. Boards approved; close expected early 2027 after shareholder and regulatory approvals. Varex completed a $490 million refinancing in March 2026.
6 min read